159 related articles for article (PubMed ID: 29959636)
1. Comparison of Ki-67 labeling index measurements using digital image analysis and scoring by pathologists.
Morioka T; Niikura N; Kumaki N; Masuda S; Iwamoto T; Yokoyama K; Ogiya R; Oshitanai R; Terao M; Tsuda B; Okamura T; Saito Y; Suzuki Y; Tokuda Y
Breast Cancer; 2018 Nov; 25(6):768-777. PubMed ID: 29959636
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the Ki67 scoring categories in breast cancer subgroups.
Niikura N; Masuda S; Kumaki N; Xiaoyan T; Terada M; Terao M; Iwamoto T; Oshitanai R; Morioka T; Tuda B; Okamura T; Saito Y; Suzuki Y; Tokuda Y
Clin Breast Cancer; 2014 Oct; 14(5):323-329.e3. PubMed ID: 24492237
[TBL] [Abstract][Full Text] [Related]
3. Effects of tissue decalcification on the quantification of breast cancer biomarkers by digital image analysis.
Gertych A; Mohan S; Maclary S; Mohanty S; Wawrowsky K; Mirocha J; Balzer B; Knudsen BS
Diagn Pathol; 2014 Nov; 9():213. PubMed ID: 25421113
[TBL] [Abstract][Full Text] [Related]
4. Comparison of visual assessment and image analysis in the evaluation of Ki-67 expression and their prognostic significance in immunohistochemically defined luminal breast carcinoma.
Arihiro K; Oda M; Ohara M; Kadoya T; Osaki A; Nishisaka T; Shiroma N; Kobayashi Y
Jpn J Clin Oncol; 2016 Dec; 46(12):1081-1087. PubMed ID: 27511992
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the Ki67 labeling index: a Japanese validation ring study.
Niikura N; Sakatani T; Arima N; Ohi Y; Honma N; Kanomata N; Yoshida K; Kadoya T; Tamaki K; Kumaki N; Iwamoto T; Sugie T; Moriya T
Breast Cancer; 2016 Jan; 23(1):92-100. PubMed ID: 24794952
[TBL] [Abstract][Full Text] [Related]
6. Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score.
Robertson S; Acs B; Lippert M; Hartman J
Breast Cancer Res Treat; 2020 Aug; 183(1):161-175. PubMed ID: 32572716
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.
Tan QX; Qin QH; Yang WP; Mo QG; Wei CY
Int J Clin Exp Pathol; 2014; 7(10):6862-70. PubMed ID: 25400769
[TBL] [Abstract][Full Text] [Related]
8. The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.
Thakur SS; Li H; Chan AMY; Tudor R; Bigras G; Morris D; Enwere EK; Yang H
PLoS One; 2018; 13(1):e0188983. PubMed ID: 29304138
[TBL] [Abstract][Full Text] [Related]
9. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67.
Tuominen VJ; Ruotoistenmäki S; Viitanen A; Jumppanen M; Isola J
Breast Cancer Res; 2010; 12(4):R56. PubMed ID: 20663194
[TBL] [Abstract][Full Text] [Related]
10. Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment.
Ayad E; Soliman A; Anis SE; Salem AB; Hu P; Dong Y
Diagn Pathol; 2018 Aug; 13(1):63. PubMed ID: 30153851
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of the free web-based image analysis application ImmunoRatio for assessment of Ki-67 labelling index in breast cancer.
Yeo MK; Kim HE; Kim SH; Chae BJ; Song BJ; Lee A
J Clin Pathol; 2017 Aug; 70(8):715-719. PubMed ID: 28298390
[TBL] [Abstract][Full Text] [Related]
12. Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer.
Horii R; Tsuda H; Masuda S; Sugita H; Togashi K; Ohno S; Akiyama F
Breast Cancer; 2020 Nov; 27(6):1058-1064. PubMed ID: 32440959
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
[TBL] [Abstract][Full Text] [Related]
14. Comparison between Ki67 labeling index determined using image analysis software with virtual slide system and that determined visually in breast cancer.
Maeda I; Abe K; Koizumi H; Nakajima C; Tajima S; Aoki H; Tsuchiya J; Tsuchiya S; Tsuchiya K; Shimo A; Tsugawa K; Ueno T; Tatsunami S; Takagi M
Breast Cancer; 2016 Sep; 23(5):745-51. PubMed ID: 26271611
[TBL] [Abstract][Full Text] [Related]
15. Automated assessment of Ki-67 in breast cancer: the utility of digital image analysis using virtual triple staining and whole slide imaging.
Hida AI; Omanovic D; Pedersen L; Oshiro Y; Ogura T; Nomura T; Kurebayashi J; Kanomata N; Moriya T
Histopathology; 2020 Sep; 77(3):471-480. PubMed ID: 32578891
[TBL] [Abstract][Full Text] [Related]
16. Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence.
Okumura Y; Nishimura R; Nakatsukasa K; Yoshida A; Masuda N; Tanabe M; Shien T; Tanaka S; Arima N; Komoike Y; Taguchi T; Iwase T; Inaji H; Ishitobi M;
Eur J Surg Oncol; 2015 Apr; 41(4):548-52. PubMed ID: 25682910
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis.
Yamazaki Y; Nakamura Y; Shibahara Y; Konosu-Fukaya S; Sato N; Kubota-Nakayama F; Oki Y; Baba S; Midorikawa S; Morimoto R; Satoh F; Sasano H
Hum Pathol; 2016 Jul; 53():41-50. PubMed ID: 26980031
[TBL] [Abstract][Full Text] [Related]
18. Digital quantification of KI-67 in breast cancer.
Del Rosario Taco Sanchez M; Soler-Monsó T; Petit A; Azcarate J; Lasheras A; Artal C; Gil M; Falo C; Pla MJ; Matias-Guiu X
Virchows Arch; 2019 Feb; 474(2):169-176. PubMed ID: 30465110
[TBL] [Abstract][Full Text] [Related]
19. Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine Diagnostics.
Abele N; Tiemann K; Krech T; Wellmann A; Schaaf C; Länger F; Peters A; Donner A; Keil F; Daifalla K; Mackens M; Mamilos A; Minin E; Krümmelbein M; Krause L; Stark M; Zapf A; Päpper M; Hartmann A; Lang T
Mod Pathol; 2023 Mar; 36(3):100033. PubMed ID: 36931740
[TBL] [Abstract][Full Text] [Related]
20. A Retrospective Analysis of Ki-67 Index and its Prognostic Significance in Over 800 Primary Breast Cancer Cases.
Thangarajah F; Enninga I; Malter W; Hamacher S; Markiefka B; Richters L; Krämer S; Mallmann P; Kirn V
Anticancer Res; 2017 Apr; 37(4):1957-1964. PubMed ID: 28373466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
